{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T07:32:17Z","timestamp":1766820737949},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T00:00:00Z","timestamp":1384819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12282-013-0503-1","type":"journal-article","created":{"date-parts":[[2013,11,18]],"date-time":"2013-11-18T10:37:27Z","timestamp":1384771047000},"page":"462-468","source":"Crossref","is-referenced-by-count":61,"title":["Prevalence and differentiation of hereditary breast and ovarian cancers in Japan"],"prefix":"10.1007","volume":"22","author":[{"given":"Seigo","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Tozaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Nomizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshie","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuji","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiichiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideko","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shozo","family":"Ohsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadao","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,19]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66\u201371.","journal-title":"Science"},{"key":"503_CR2","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","volume":"68","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet. 2001;68:700\u201310.","journal-title":"Am J Hum Genet"},{"key":"503_CR3","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/djj465","volume":"98","author":"HA Risch","year":"2006","unstructured":"Risch HA, McLaughlin JR, Cole DE, et al. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98:1694\u2013706.","journal-title":"J Natl Cancer Inst"},{"key":"503_CR4","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/jnci\/93.16.1215","volume":"93","author":"N Loman","year":"2001","unstructured":"Loman N, Johannsson O, Kristoffersson U, et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 2001;93:1215\u201323.","journal-title":"J Natl Cancer Inst"},{"key":"503_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/1097-0215(20010101)91:1<83::AID-IJC1013>3.0.CO;2-5","volume":"91","author":"N Ikeda","year":"2001","unstructured":"Ikeda N, Miyoshi Y, Yoneda K, et al. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families. Int J Cancer. 2001;91:83\u20138.","journal-title":"Int J Cancer"},{"key":"503_CR6","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Genetic\/Familial High-Risk Assessment: Breast and Ovarian ver.1.2010 and ver.1.2011."},{"key":"503_CR7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1200\/JCO.1998.16.7.2417","volume":"16","author":"TS Frank","year":"1998","unstructured":"Frank TS, Manley SA, Olopade OI, et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol. 1998;16:2417\u201325.","journal-title":"J Clin Oncol"},{"key":"503_CR8","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","volume":"30","author":"JP Schouten","year":"2002","unstructured":"Schouten JP, McElgunn CJ, Waaijer R, et al. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 2002;30:e57.","journal-title":"Nucleic Acids Res"},{"key":"503_CR9","first-page":"1449","volume":"63","author":"FB Hogervorst","year":"2003","unstructured":"Hogervorst FB, Nederlof PM, Gill JP, et al. Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method. Cancer Res. 2003;63:1449\u201353.","journal-title":"Cancer Res"},{"key":"503_CR10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjc.6602121","volume":"9","author":"DJ Bunyan","year":"2004","unstructured":"Bunyan DJ, Eccles DM, Sillibourne J, et al. Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification. Br J Cancer. 2004;9:1155\u20139.","journal-title":"Br J Cancer"},{"key":"503_CR11","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1111\/j.1349-7006.2008.00944.x","volume":"99","author":"K Sugano","year":"2008","unstructured":"Sugano K, Nakamura S, Ando J, et al. Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast\/ovarian cancer. Cancer Sci. 2008;99:1967\u201376.","journal-title":"Cancer Sci"},{"key":"503_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","volume":"19","author":"SR Young","year":"2009","unstructured":"Young SR, Pilarski RT, Donenberg T, et al. The prevalence of BRCA1 mutations among young women with triple-negative breast cancer. BMC Cancer. 2009;19:86.","journal-title":"BMC Cancer"},{"key":"503_CR13","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s10549-012-2021-9","volume":"134","author":"F Fostira","year":"2012","unstructured":"Fostira F, Tsitlaidou M, Papadimitriou C, et al. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study. Breast Cancer Res Treat. 2012;134:353\u201362.","journal-title":"Breast Cancer Res Treat"},{"key":"503_CR14","first-page":"3144","volume":"7","author":"M Sekine","year":"2001","unstructured":"Sekine M, Nagata H, Tsuji S, Japanese Familial Ovarian Cancer Study Group, et al. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res. 2001;7:3144\u201350.","journal-title":"Clin Cancer Res"},{"key":"503_CR15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/01913120500521281","volume":"30","author":"B Bellosillo","year":"2006","unstructured":"Bellosillo B, Tusquets I. Pitfalls and caveats in BRCA sequencing. Ultrastruct Pathol. 2006;30:229\u201335.","journal-title":"Ultrastruct Pathol"},{"key":"503_CR16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/humu.20169","volume":"25","author":"S Mazoyer","year":"2005","unstructured":"Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat. 2005;25:415\u201322.","journal-title":"Hum Mutat"},{"key":"503_CR17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10549-010-0745-y","volume":"124","author":"I Ticha","year":"2010","unstructured":"Ticha I, Kleibl Z, Stribrna J, et al. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast\/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat. 2010;124:337\u201347.","journal-title":"Breast Cancer Res Treat"},{"key":"503_CR18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10549-010-0817-z","volume":"125","author":"MD Sluiter","year":"2011","unstructured":"Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat. 2011;125:325\u201349.","journal-title":"Breast Cancer Res Treat"},{"key":"503_CR19","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/humu.20723","volume":"29","author":"S Engert","year":"2008","unstructured":"Engert S, Wappenschmidt B, Betz B, et al. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases. Hum Mutat. 2008;29:948\u201358.","journal-title":"Hum Mutat"},{"key":"503_CR20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2217\/fon.10.5","volume":"6","author":"K Ready","year":"2010","unstructured":"Ready K, Litton JK, Arun BK. Clinical application of breast cancer risk assessment models. Future Oncol. 2010;6:355\u201365.","journal-title":"Future Oncol"},{"key":"503_CR21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/jnci\/djq088","volume":"102","author":"E Amir","year":"2010","unstructured":"Amir E, Freedman OC, Seruga B, et al. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102:680\u201391.","journal-title":"J Natl Cancer Inst"},{"key":"503_CR22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00268-011-1406-y","volume":"36","author":"A Kwong","year":"2012","unstructured":"Kwong A, Wong CH, Suen DT, et al. Accuracy of BRCA1\/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort. World J Surg. 2012;36:702\u201313.","journal-title":"World J Surg"},{"key":"503_CR23","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10549-012-2022-8","volume":"134","author":"E Kang","year":"2012","unstructured":"Kang E, Park SK, Yang JJ, Korean Breast Cancer Society, et al. Accuracy of BRCA1\/2 mutation prediction models in Korean breast cancer patients. Breast Cancer Res Treat. 2012;134:1189\u201397.","journal-title":"Breast Cancer Res Treat"},{"key":"503_CR24","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1200\/JCO.2002.05.121","volume":"20","author":"DA Berry","year":"2002","unstructured":"Berry DA, Iversen ES Jr, Gudbjartsson DF, et al. BRCAPRO validation, sensitivity of genetic testing of BRCA1\/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol. 2002;20:2701\u201312.","journal-title":"J Clin Oncol"},{"key":"503_CR25","first-page":"1","volume":"38","author":"NM Lindor","year":"2008","unstructured":"Lindor NM, McMaster ML, Lindor CJ, et al. Concise handbook of familial cancer susceptibility syndromes\u2014second edition. J Natl Cancer Inst Monogr. 2008;38:1\u201393.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"503_CR26","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1245\/s10434-009-0638-7","volume":"16","author":"CA Garcia-Etienne","year":"2009","unstructured":"Garcia-Etienne CA, Barile M, Gentilini OD, et al. Breast-conserving surgery in BRCA1\/2 mutation carriers: are we approaching an answer? Ann Surg Oncol. 2009;16:3380\u20137.","journal-title":"Ann Surg Oncol"},{"key":"503_CR27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-009-0685-6","volume":"120","author":"YM Kirova","year":"2010","unstructured":"Kirova YM, Savignoni A, Sigal-Zafrani B, et al. Is the breast-conserving treatment with radiotherapy appropriate in BRCA1\/2 mutation carriers? Long-term results and review of the literature. Breast Cancer Res Treat. 2010;120:119\u201326.","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-013-0503-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-013-0503-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-013-0503-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T06:54:31Z","timestamp":1564728871000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-013-0503-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,19]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1007\/s12282-013-0503-1","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,19]]}}}